Progestogen only contraception in women with congenital heart disease

Progestogen only contraception in women with congenital heart disease

AbstractBackground There is little information of progestogen-only contraceptives in patients with congenital heart disease (CHD) on the long-term.Objective To evaluate the use of contraception in patients with CHD. We studied both short-acting reversible contraceptives (SARCs), oral progestin-only...

Full description

Bibliographic Details
Main Authors: Francesc Baró-Mariné, Antonia Pijuan-Domènech, Maria del Mar Goya, Elena Suárez-Edo, Berta Miranda-Barrio, Laura Dos-Subirà, Maria Luisa Pancorbo, Ignacio Ferreira-Gonzalez, Elena Carreras-Moratonas
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Journal of Obstetrics and Gynaecology
Subjects:
Congenital heart disease
progesterone only contraception
LARCs methods (long-acting reversible contraceptive)
SARCs methods (short-acting reversible contraceptive)
Online Access:https://www.tandfonline.com/doi/10.1080/01443615.2024.2320296

Internet

https://www.tandfonline.com/doi/10.1080/01443615.2024.2320296

Similar Items